Piramal Critical Care Joins Forces with Blue-Zone Technologies
Piramal Critical Care, Inc. (PCC), a subsidiary of Piramal Pharma Limited, has embarked on an exciting partnership with Blue-Zone Technologies Ltd. This collaboration focuses on a comprehensive technological solution aimed at capturing and recycling waste anaesthetic gases, thus creating a more sustainable methodology for anesthesia practices.
Environmental Benefits and Technological Innovations
The innovative technology provided by Blue-Zone is designed for the efficient capture, collection, and processing of waste anaesthetic gases. This effort marks a significant commitment to reducing the environmental impact of volatile anesthetics used during various medical procedures. With these advancements, healthcare providers can effectively minimize the ecological footprint associated with waste anaesthetic gases while still ensuring high-quality care for patients worldwide.
Expanding Reach Across Europe
Pending necessary regulatory approvals in Europe, Blue-Zone plans to introduce its Phoenix Deltasorb waste anaesthetic gas capture system to PCC's clientele, initially targeting key markets in countries like France and Germany. Under this agreement, Blue-Zone will take the lead in managing all supply-related activities of its systems in healthcare facilities, while PCC will leverage Blue-Zone's technology to process captured gas into Sevoflurane USP for use in Canada.
Broadening Horizons for Future Collaboration
Both Piramal Critical Care and Blue-Zone anticipate expansion of their waste anaesthetic gas capture initiatives into additional regions. By broadening the geographical scope of their collaboration, they aim to enhance the overall effectiveness and reach of their sustainable practices, ultimately benefiting patients and healthcare providers alike.
An Emphasis on Responsible Care and Sustainability
Jeff Hampton, President and COO of Piramal Critical Care, expressed enthusiasm about the partnership, highlighting its role in advancing sustainable healthcare practices. He stated, "Piramal Critical Care is proud to partner with Blue-Zone on this innovative technology to help reduce waste and minimize environmental impact. Through this collaboration, hospitals can select anaesthetic solutions that align with clinical needs while supporting broader goals of sustainability. ”
Inhaled anaesthetics represent a critical component of healthcare, enabling essential procedures for patients globally. As a leading manufacturer in this space, Piramal Pharma is dedicated to balancing clinical performance with environmental responsibility, ensuring critical care remains accessible while evolving towards more sustainable practices.
About Piramal Critical Care and its Global Presence
Piramal Critical Care stands as a global authority in anaesthesia, pain management, and intrathecal therapy. With a strong international presence, PCC supplies essential medications to hospitals in over 100 territories. Their product range comprises inhaled anaesthetics, intrathecal solutions for pain management, plasma volume expanders, and various injectables. With state-of-the-art manufacturing facilities, PCC adheres to stringent global regulatory standards, ensuring high-quality production and efficacy.
Piramal Pharma Ltd Overview
Piramal Pharma Limited (PPL), listed on the NSE and BSE, encompasses a diverse portfolio of products and services, supported by 17 global development and manufacturing sites. In addition to its flagship brands including PCC, PPL engages in pharmaceutical solutions and consumer healthcare products. Their strategic partnerships extend the reach of their innovative products within the healthcare industry.
Innovative Solutions From Blue-Zone Technologies
Blue-Zone Technologies, based in Ontario, Canada, specializes in cleantech solutions geared toward the recovery and processing of waste anaesthetic gases. Focused on environmental preservation, Blue-Zone integrates waste management with the production of volatile anaesthetics, facilitating responsible healthcare practices through strategic partnerships worldwide.
For queries and engagement about Piramal Critical Care or Blue-Zone Technologies, interested parties can reach out through the respective channels indicated in their official communications.
Frequently Asked Questions
What is the focus of the partnership between Piramal and Blue-Zone?
The collaboration focuses on capturing and recycling waste anaesthetic gases to reduce environmental impacts in healthcare.
Where will Blue-Zone's systems initially be introduced?
Blue-Zone's systems will be introduced in Europe, specifically in France and Germany, pending regulatory approvals.
What will PCC do with the captured waste anaesthetic gases?
PCC will process captured gases using Blue-Zone’s technology to produce Sevoflurane USP for human use in Canada.
Why are inhaled anaesthetics considered important?
Inhaled anaesthetics are vital for various medical procedures, enabling safe and effective treatment for patients globally.
What is the global reach of Piramal Critical Care?
Piramal Critical Care delivers medication to hospitals in over 100 countries, establishing a significant international presence.
